Skip to content

The effect of electrical stimulation in people with shoulder pain

The effect of electrical stimulation point microcurrent in individuals with Chronic Myofascial Pain Syndrome in the upper trapezius muscle

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6tbygn
Enrollment
Unknown
Registered
2016-10-10
Start date
2016-08-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Syndrome of chronic myofascial pain

Interventions

The intervention will be performed as two groups for treatment with microcurrent electrical stimulation point, three times a week, for one week. Electrical stimulation is applied in two groups of volu
Other
E02.331

Sponsors

Universidade Federal de Alfenas
Lead Sponsor
Universidade Federal de Alfenas
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Individuals aged 18 to 40, that are experiencing persistent, spontaneous pain in the upper trapezius muscle region for more than 3 months. On physical examination, individuals must have at least one active trigger point in one or both sides of the muscle. The inclusion criteria for the presence of active trigger point in upper trapezius muscle are: Presence of a palpable taut band in the muscle; Presence of a hypersensitive lump in the taut band of muscle; Standard playback typical trigger point referred pain in response to palpation; Standard spontaneous presence of typical referred pain and / or recognition that pain patient and family; Pain of at least 3 cm on a visual analogue scale (VAS) from 0 cm (no pain) to 10 cm (worst pain imaginable).

Exclusion criteria

Exclusion criteria: Individuals that are experiencing muscle pain due to fibromyalgia; cervical radiculopathy; neck pain; degenerative cervical changes; History of surgery in the cervical spine or shoulder; history of fracture; Tendinitis in the neck and shoulder area; Cancer; Cervical myelopathy; atypical facial neuralgia; myopathy; Rheumatism; Multiple sclerosis; Tuberculosis; recent medication change; Use of anti-inflammatory or pain medications; physical therapy interventions (acupuncture, chiropractic, massage); weight lifters; Other chronic pain conditions (chronic fatigue syndrome and Lyme disease); cardiac pacemakers; Pregnancy; Menstrual period; uncontrolled hypertension; neurological or psychiatric disorders; Disorders of the skin and vascular disorders; sensitivity changes.

Design outcomes

Primary

MeasureTime frame
Changes in the physical and functional parameters in the upper trapezius muscle in individuals with chronic myofascial pain syndrome, in a period of a week, checked by Visual Analogue Scale; the SF-36 questionnaire; the pressure algometry; infrared thermography; and electromyography, from finding a variation of at least 5% in the pre and post intervention measurements.

Secondary

MeasureTime frame
Secondary outcomes aren't expected.

Countries

Brazil

Contacts

Public ContactJosie da Silva

Universidade Federal de Alfenas

resendejr@yahoo.com.br+55 (35) 3292-2377

Outcome results

None listed

Source: REBEC (via WHO ICTRP)